Latest

13:28
[ CSOP KOSPI 200 ETF (03121.HK) Falls 9.98% in Afternoon Trade, Latest Price at HKD 5.995 ] NewTimeSpace News: As of 13:26 on July 13, CSOP KOSPI 200 ETF (03121.HK) was down 9.98%, with the latest price at HKD 5.995.
Tag： CSOP KOSPI 200 ETFETF03121.HK
13:26
[ CSOP SK Hynix Daily (2x) Leveraged Product (07709.HK) Falls 28.86% Intraday, Turnover at HKD 12.414 Billion ] NewTimeSpace News: As of July 13, CSOP SK Hynix Daily (2x) Leveraged Product (07709.HK) was down 28.86%, with the latest price at HKD 63.600.
Tag： CSOP SK Hynix Daily (2x) Leveraged ProductETF07709.HK
13:22
[ TASTEGOURMET GP (08371.HK): To Open Fourth Golden Dragon Teppanyaki Restaurant in Hong Kong at Taikoo Shing ] NewTimeSpace News: Tastegourmet GP (08371.HK) announced that its wholly-owned subsidiary has entered into a new tenancy agreement to launch a new Golden Dragon Teppanyaki restaurant in Taikoo Shing, Hong Kong. The four-year lease took effect on 1 July 2026, and the new outlet is scheduled to commence operation in the third quarter of 2026, marking the Group’s fourth Golden Dragon Teppanyaki restaurant in Hong Kong.
Tag： TASTEGOURMET GP08371.HKBusiness Development
13:18
[ ROAD KING INFRA (01098.HK): Take-up of Offshore Restructuring Support Agreement Surpasses 60% ] NewTimeSpace News: Road King Infrastructure (01098.HK) announced that upon expiry of the Early Bird RSA Fee Deadline on 10 July 2026, holders representing more than 60% of the aggregate principal amount of the Existing Notes and Existing Perpetual Securities have acceded to the Restructuring Support Agreement (RSA). Remaining holders are reminded that the General RSA Fee Deadline is 5:00 p.m., Hong Kong Time, on 24 July 2026.
Tag： ROAD KING INFRA01098.HKoffshore restructuring
13:15
[ SSY GROUP (02005.HK): Baloxavir Marboxil API Approved for Registration, Becoming the Third Domestic Enterprise with Such Approval ] NewTimeSpace News: SSY GROUP (02005.HK) announced that Baloxavir Marboxil active pharmaceutical ingredient (API) of the Group has been approved and registered by NMPA for use in marketed formulations, making the Company the third domestic enterprise to obtain the approval. Baloxavir Marboxil is mainly indicated for the treatment of influenza A and B viruses.
Tag： SSY Group02005.HKdrug registration approval
11:21
[ E Fund CSI Banks ETF(516310) rises 1.74%, with a scale increase of 29.3307 million yuan over the past week ] NewTimeSpace (newtimespace.com) News, as of 11:16 on July 13, 2026, E Fund Bank ETF (516310) rose 1.74%, with the latest price at 1.29 yuan.In terms of scale, E Fund Bank ETF saw a significant increase of 29.3307 million yuan in scale over the past week, with the new scale increase ranking 1/11 among comparable funds.In terms of shares, E Fund Bank ETF experienced a significant increase of 8.10 million units in share count over the past week, with the new share increase ranking 1/11 among comparable funds.
Tag： ETF516310.SHE Fund CSI Banks ETF
11:19
[ Csop Ftse Hk-Korea Tech+ Index Etf (03431.HK) Falls 6.20% in Morning Trade, Latest NAV at HKD 10.782 ] NewTimeSpace News: As of 11:16 on July 13, Csop Ftse Hk-Korea Tech+ Index Etf (03431.HK) was down 6.20%, with the latest price at HKD 10.130.
Tag： 03431.HKCsop Ftse Hk-Korea Tech+ Index ETFETF
11:16
[ CSOP STAR 50 Index ETF (03109.HK) Falls 2.29% Intraday, Turnover at HKD 15.108 Million ] NewTimeSpace News: As of July 13, CSOP STAR 50 Index ETF (03109.HK) was down 2.29%, with the latest price at HKD 19.640.
Tag： CSOP STAR 50 Index ETF03109.HKETF
11:16
[ China Universal CSI Chinese Medicine ETF(560080) rises 3.21%, with a share increase of 27.00 million units over the past week ] NewTimeSpace (newtimespace.com) News, as of 11:11 on July 13, 2026, China Universal Traditional Chinese Medicine ETF (560080) rose 3.21%, with the latest price at 0.97 yuan.In terms of scale, China Universal Traditional Chinese Medicine ETF saw a significant increase of 9.0833 million yuan in scale over the past week, with the new scale increase ranking 1/4 among comparable funds.In terms of shares, China Universal Traditional Chinese Medicine ETF experienced a significant increase of 27.00 million units in share count over the past week, with the new share increase ranking 1/4 among comparable funds.
Tag： ETF560080.SHChina Universal CSI Chinese Medicine ETF
11:07
[ Global X China Robotics And AI ETF (02807.HK) Falls 3.92% in Morning Trade, Turnover at HKD 4.5883 Million ] NewTimeSpace News: As of 11:05 on July 13, Global X China Robotics And AI ETF (02807.HK) was down 3.92%, with the latest price at HKD 59.800.
Tag： ETFGlobal X China Robotics And Ai Etf,02807.HK
10:56
[ CSOP SK Hynix Daily (2x) Leveraged Product (07709.HK) Falls 22.17% in Morning Trade, Turnover at HKD 6.798 Billion ] NewTimeSpace News: As of 10:47 on July 13, CSOP SK Hynix Daily (2x) Leveraged Product (07709.HK) was down 22.17%, with the latest price at HKD 69.580.
Tag： 07709.HKCSOP SK Hynix Daily (2x) Leveraged ProductETF
10:55
[ ETF Financing Ranking | Guotai CSI All Share Investment Banking & Brokerage ETF (512880) had a net financing buy-in of CNY 33.12 million, ranked in the top 2 among comparable funds ] NewTimeSpace (newtimespace.com) News, Jul 10, 2026, Guotai CSI All Share Investment Banking & Brokerage ETF (512880.SH) had a net financing buy-in of CNY 33.12 million, ranked in the top 2 among comparable funds.
Tag： Guotai CSI All Share Investment Banking & Brokerage ETF512880.SHNewTimeSpace
10:48
[ ETF Financing Ranking | Hwabao WP CSI All Share Investment Banking & Brokerage ETF (512000) had a net financing buy-in of CNY 40.88 million, ranked first among comparable funds ] NewTimeSpace (newtimespace.com) News, Jul 10, 2026, Hwabao WP CSI All Share Investment Banking & Brokerage ETF (512000.SH) had a net financing buy-in of CNY 40.88 million, ranked first among comparable funds.
Tag： Hwabao WP CSI All Share Investment Banking & Brokerage ETF512000.SHNewTimeSpace
10:46
[ ETF Short Selling Ranking | China Southern CSI 500 ETF (510500) had a net short selling for CNY 124.74 million, ranked first in the entire market ] NewTimeSpace (newtimespace.com) News, Jul 10, 2026, China Southern CSI 500 ETF (510500.SH) had a net short selling for CNY 124.74 million, ranked first in the entire market.
Tag： China Southern CSI 500 ETF510500.SHNewTimeSpace
10:44
[ ETF Financing Ranking | Guotai CSI Semiconductor Material Equipment Theme ETF (159516) had a net financing buy-in of CNY 74.87 million, ranked in the top 2 among comparable funds ] NewTimeSpace (newtimespace.com) News, Jul 10, 2026, Guotai CSI Semiconductor Material Equipment Theme ETF (159516.SZ) had a net financing buy-in of CNY 74.87 million, ranked in the top 2 among comparable funds.
Tag： Guotai CSI Semiconductor Material Equipment Theme ETF159516.SZNewTimeSpace
10:43
[ iShares Core MSCI AC Asia ex Japan Index ETF (03010.HK) Falls 1.82% in Morning Trade, Latest NAV at HKD 88.672 ] NewTimeSpace News: As of 10:41 on July 13, iShares Core MSCI AC Asia ex Japan Index ETF (03010.HK) was down 1.82%, with the latest price at HKD 87.500.
Tag： 03010.HKiShares Core MSCI AC Asia ex Japan Index ETFETF
10:35
[ CSOP NVIDIA Daily (2x) Leveraged Product (07788.HK) Rises 6.93% in Morning Trade, Latest Price at HKD 160.500 ] NewTimeSpace News: As of 10:32 on July 13, CSOP NVIDIA Daily (2x) Leveraged Product (07788.HK) was up 6.93%, with the latest price at HKD 160.500.
Tag： CSOP NVIDIA Daily (2x) Leveraged ProductETF07788.HK
10:29
[ Global X Hang Seng TECH ETF (02837.HK) Rises 0.86% in Morning Trade, Latest NAV at HKD 5.850 ] NewTimeSpace News: As of 10:28 on July 13, Global X Hang Seng TECH ETF (02837.HK) was up 0.86%, with the latest price at HKD 5.890.
Tag： 02837.HKGlobal X Hang Seng TECH ETFETF
10:28
[ ABBISKO-B (02256.HK): Oral Pan-KRAS Inhibitor ABSK211 Cleared by FDA for Phase I Trial in KRAS-Altered Solid Tumours ] NewTimeSpace News: ABBISKO-B (02256.HK) announced on 13 July that ABSK211, an oral pan-KRAS inhibitor, has obtained FDA clearance for Phase I clinical development in advanced solid tumours with KRAS alterations. Preclinical data demonstrate broad potency against multiple KRAS variants and synergistic anti-tumour efficacy in combination regimens. The candidate has secured IND approvals in both China and the U.S. The Company reminds investors of uncertainties in drug development and approval processes.
Tag： ABBISKO-B02256.HKClinical Trial
10:26
[ CSOP KOSPI 200 ETF (03121.HK) Falls 6.01% in Morning Trade, Turnover at HKD 26.5766 Million ] NewTimeSpace News: As of 10:23 on July 13, CSOP KOSPI 200 ETF (03121.HK) was down 6.01%, with the latest price at HKD 6.260.
Tag： CSOP KOSPI 200 ETFETF03121.HK
Previous1..297298 299300301..581     581 pages total
×
Share to WeChat

Open WeChat, use "Scan," and share to my Moments